Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

Acute Manic Relapse with Dexfenfluramine

Mahendran

  • KMID: 2171285
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):44-44.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tardive Dyskinesia: Treatment with Aripiprazole

Kang NR, Kim MD

  • KMID: 2171279
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):1-8.
Tardive dyskinesia is characterized by choreiform movements, or rhythmic abnormal involuntary movements of the face, mouth, tongue, trunk, and limbs. It is frequently associated with the use of neuroleptic medications....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Predictors of Drug Response in Patients with Obsessive-Compulsive Disorder

Kim CH, Jeong JW, Kim EJ, Shin YS, Suh HS, Lee HS, Koo MS

  • KMID: 2171282
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):23-28.
OBJECTIVE: The aim of this study was to evaluate which clinical variables might influence the antiobsessional responses to proserotonergic drugs in a sample of patients with obsessive-compulsive disorder (OCD). METHODS: Two...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Central Nervous System Drug Evaluation Using Positron Emission Tomography

Sekine M, Maeda J, Shimada H, Nogami T, Arakawa R, Takano H, Higuchi M, Ito H, Okubo Y, Suhara T

  • KMID: 2171280
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):9-16.
In conventional pharmacological research in the field of mental disorders, pharmacological effect and dose have been estimated by ethological approach and in vitro data of affinity to the site of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antipsychotics Prescribing Patterns of Patients with Schizophrenia Admitted to Korean General Hospital Psychiatric Unit: 2001 to 2008

Choi HJ, Jung SH, Kang MH, Lee JS, Bae JN, Kim CE

  • KMID: 2171281
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):17-22.
OBJECTIVE: Although the standard of treatment for schizophrenia is antipsychotic monotherapy, overall psychotropic polypharmacy including antipsychotic polypharmacy is increasingly practiced by clinicians. However, there are very few studies that assess...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Aripiprazole and Haloperidol on Fos-like Immunoreactivity in the Prefrontal Cortex and Amygdala

Park JI, Zhao T, Huang GB, Sui ZY, Li CR, Han EH, Chung YC

  • KMID: 2171284
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):36-43.
OBJECTIVE: Aripiprazole, a dopamine system stabilizer, shows efficacy against both negative symptoms and positive symptoms in patients with schizophrenia. The aim of this study was to investigate the effects of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea

Kim BN, Kim YN, Cheong US, Kim JW, Hwang JW, Shin MS, Cho SC, Korean OROS-MPH Study Group

  • KMID: 2171283
  • Clin Psychopharmacol Neurosci.
  • 2011 Apr;9(1):29-35.
OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of methylphenidate HCL OROS extended-release (OROS-MPH) among children with attention deficit hyperactivity disorder (ADHD) who had been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr